Progress Report – ACCURATE Study – February 2026

ACCURATE Study (UroCCR No. 99)

With 12,000 new cases diagnosed annually in France, kidney cancer ranks as the third most common urological tumour in adults. In recent years, minimally invasive kidney-sparing surgery using robotic assistance has become the preferred treatment approach.

The ACCURATE study aims to further improve the quality of surgical procedures by guiding the surgeon with advanced 3D modelling.

To date, 687 patients have been included in this study.

▶ + 17 new patients in February 2026.

Many thanks to everyone for your continued involvement!